Journal
EUROPEAN JOURNAL OF OPHTHALMOLOGY
Volume 17, Issue 2, Pages 269-271Publisher
WICHTIG EDITORE
DOI: 10.1177/112067210701700220
Keywords
bevacizumab; intravitreal injection; neovascular glaucoma; retinal artery occlusion
Categories
Ask authors/readers for more resources
PURPOSE. To report a case of neovascular glaucoma due to central retinal artery occlusion treated with a single intravitreal injection of bevacizumab. METHODS. A 68-year-old patient with a 10-week history of central retinal artery occlusion presented with neovascularization of the iris and the angle and intraocular pressure of 30 mmHg. The patient received a single injection of 1.25 mg bevacizumab in 0.1 mL intravitreally. RESULTS. Iris and angle neovascularization regressed within 48 hours of the injection. Intraocular pressure dropped from 30 to 15 mmHg, and there was marked improvement in patient comfort. Panretinal photocoagulation was applied 4 weeks after the injection. CONCLUSIONS. Bevacizumab seems to be a useful adjunct to panretinal photocoagulation in the treatment of neovascular glaucoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available